Wendy future of retail top

Dane Hallberg

Titan teams with AllianceRx Walgreens Prime

Titan teams with AllianceRx Walgreens Prime

SOUTH SAN FRANCISCO, Calif.  — Titan Pharmaceuticals announced Thursday the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan’s unique six-month maintenance treatment for opioid use disorder (OUD) in eligible patients. Titan expects the majority of Probuphine sales in the

PP_1170x120_10-25-21